Pison, a developer of an AI-powered wearable cognitive health assessment system, announced an equity investment from Samsung Ventures, the corporate venture capital arm of Samsung Electronics based in Seoul, South Korea.
The funding details were not disclosed.
Pison was founded in 2016 with funding from the Massachusetts Institute of Technology, the National Science Foundation, and the ALS Association to help patients with neurodegenerative disorders better navigate a world made smaller by their diseases.
Since its founding, Pison has been developing a mobile app-connected biosensor system that detects brain activity from three nerve bundles in the wrist. Using both active and passive AI algorithms, it extracts neurocognitive data, providing insights into mental acuity and impairment from poor sleep, chronic fatigue, anxiety, neurodegenerative conditions, drugs, alcohol, and subconcussive brain injuries.
“We’re honored to have Samsung Venture Investment Corporation involved in this funding journey for Pison, as their support offers vital resources to bring forward transformative solutions with meaningful societal impact,” said John Croteau, CEO of Pison.
“Our mobile apps and subscription services aim to redefine cognitive performance and productivity—whether at home, on the athletic field, in the workplace, or within mission-critical job functions,” added John Croteau.